ImmuCell Corporation Operating Lease Cost
ImmuCell Corporation (ICCC) reported Operating Lease Cost of $404.53 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-03-30
- ImmuCell Corporation operating lease, cost for the quarter ending 2025-12-31 was $84.93K, a 20.54% decline year-over-year.
- ImmuCell Corporation operating lease, cost for the quarter ending 2025-09-30 was $106.06K, a 0.77% decline year-over-year.
- ImmuCell Corporation operating lease, cost for the quarter ending 2025-06-30 was $106.66K, a 0.20% decline year-over-year.
- ImmuCell Corporation operating lease, cost for the quarter ending 2025-03-31 was $106.88K, a 0.00% change year-over-year.
- ImmuCell Corporation operating lease, cost for fiscal 2025 was $404.53K, a 5.38% decline from fiscal 2024.
- ImmuCell Corporation operating lease, cost for fiscal 2024 was $427.52K, a 22.52% increase from fiscal 2023.
- ImmuCell Corporation operating lease, cost for fiscal 2023 was $348.93K, a 133.90% increase from fiscal 2022.
- ImmuCell Corporation operating lease, cost for fiscal 2022 was $149.18K.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 3 month as first filed | Operating Lease, Cost 6 month | Operating Lease, Cost 6 month as first filed | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month | Operating Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | $84.93K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $190.99K derived: sum of 2 quarters · filed 2026-03-30 | $297.65K derived: sum of 3 quarters · filed 2026-03-30 | $404.53K 10-K · filed 2026-03-30 | |||
| 2025-09-30 | $106.06K 10-Q · filed 2025-11-13 | $212.72K derived: sum of 2 quarters · filed 2025-11-13 | $319.60K 10-Q · filed 2025-11-13 | $426.48K derived: sum of 4 quarters · filed 2026-03-30 | |||
| 2025-06-30 | $106.66K 10-Q · filed 2025-08-14 | $213.54K 10-Q · filed 2025-08-14 | $320.42K derived: sum of 3 quarters · filed 2026-03-30 | $427.30K derived: sum of 4 quarters · filed 2026-03-30 | |||
| 2025-03-31 | $106.88K 10-Q · filed 2025-05-14 | $213.76K derived: sum of 2 quarters · filed 2026-03-30 | $320.64K derived: sum of 3 quarters · filed 2026-03-30 | $427.52K derived: sum of 4 quarters · filed 2026-03-30 | |||
| 2024-12-31 | $106.88K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $213.76K derived: sum of 2 quarters · filed 2026-03-30 | $320.64K derived: sum of 3 quarters · filed 2026-03-30 | $427.52K 10-K · filed 2026-03-30 | |||
| 2024-09-30 | $106.88K 10-Q · filed 2025-11-13 | $213.76K derived: sum of 2 quarters · filed 2025-11-13 | $320.64K 10-Q · filed 2025-11-13 | $424.62K derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2024-06-30 | $106.88K 10-Q · filed 2025-08-14 | $213.76K 10-Q · filed 2025-08-14 | $317.74K derived: sum of 3 quarters · filed 2025-08-14 | $416.45K derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | $106.88K 10-Q · filed 2025-05-14 | $210.85K derived: sum of 2 quarters · filed 2025-05-14 | $309.57K derived: sum of 3 quarters · filed 2025-05-14 | $408.28K derived: sum of 4 quarters · filed 2025-05-14 | |||
| 2023-12-31 | $103.97K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $202.69K derived: sum of 2 quarters · filed 2025-03-28 | $301.40K derived: sum of 3 quarters · filed 2025-03-28 | $348.93K 10-K · filed 2025-03-28 | |||
| 2023-09-30 | $98.71K 10-Q · filed 2024-11-13 | $197.43K derived: sum of 2 quarters · filed 2024-11-13 | $244.95K 10-Q · filed 2024-11-13 | $303.67K derived: sum of 4 quarters · filed 2024-11-13 | |||
| 2023-06-30 | $98.71K 10-Q · filed 2024-08-13 | $146.24K 10-Q · filed 2024-08-13 | $4.37M 10-Q · filed 2023-08-10 | $204.95K derived: sum of 3 quarters · filed 2024-08-13 | $235.19K derived: sum of 4 quarters · filed 2024-08-13 | ||
| 2023-03-31 | $47.53K 10-Q · filed 2024-05-14 | $2.24M 10-Q · filed 2023-05-11 | $106.24K derived: sum of 2 quarters · filed 2024-05-14 | $136.47K derived: sum of 3 quarters · filed 2024-05-14 | $166.71K derived: sum of 4 quarters · filed 2024-05-14 | ||
| 2022-12-31 | $58.71K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $88.95K derived: sum of 2 quarters · filed 2024-04-01 | $119.19K derived: sum of 3 quarters · filed 2024-04-01 | $149.18K 10-K · filed 2024-04-01 | $2.25M 10-K · filed 2023-03-29 | ||
| 2022-09-30 | $30.24K 10-Q · filed 2023-11-13 | $60.47K derived: sum of 2 quarters · filed 2023-11-13 | $90.47K 10-Q · filed 2023-11-13 | $119.96K derived: sum of 4 quarters · filed 2023-11-13 | |||
| 2022-06-30 | $30.24K 10-Q/A · filed 2022-11-21 | $60.23K 10-Q/A · filed 2022-11-21 | $89.73K derived: sum of 3 quarters · filed 2022-11-21 | $119.23K derived: sum of 4 quarters · filed 2022-11-21 | |||
| 2022-03-31 | $29.99K 10-Q/A · filed 2022-11-21 | $59.49K derived: sum of 2 quarters · filed 2022-11-21 | $88.99K derived: sum of 3 quarters · filed 2022-11-21 | $118.49K derived: sum of 4 quarters · filed 2022-11-21 | |||
| 2021-12-31 | $29.50K derived: 10-Q/A 12 month − 10-Q 9 month · filed 2022-11-21 | $59.00K derived: sum of 2 quarters · filed 2022-11-21 | $88.50K derived: sum of 3 quarters · filed 2022-11-21 | $118.00K 10-Q/A · filed 2022-11-21 | |||
| 2021-09-30 | $29.50K 10-Q · filed 2022-11-21 | $59.00K derived: sum of 2 quarters · filed 2022-11-21 | $88.50K 10-Q · filed 2022-11-21 | $118.00K derived: sum of 4 quarters · filed 2022-11-21 | |||
| 2021-06-30 | $29.50K 10-Q/A · filed 2022-11-21 | $59.00K 10-Q/A · filed 2022-11-21 | $88.50K derived: sum of 3 quarters · filed 2022-11-21 | $118.00K derived: sum of 4 quarters · filed 2022-11-21 | |||
| 2021-03-31 | $29.50K 10-Q/A · filed 2022-11-21 | $59.00K derived: sum of 2 quarters · filed 2022-11-21 | $88.50K derived: sum of 3 quarters · filed 2022-11-21 | $118.00K derived: sum of 4 quarters · filed 2022-11-21 | |||
| 2020-12-31 | $29.50K derived: 10-Q/A 12 month − 10-Q 9 month · filed 2022-11-21 | $59.00K derived: sum of 2 quarters · filed 2022-11-21 | $88.50K derived: sum of 3 quarters · filed 2022-11-21 | $104.09K 10-Q/A · filed 2022-11-21 | |||
| 2020-09-30 | $29.50K 10-Q · filed 2021-11-15 | $59.00K derived: sum of 2 quarters · filed 2021-11-15 | $74.59K 10-Q · filed 2021-11-15 | ||||
| 2020-06-30 | $29.50K 10-Q · filed 2021-08-12 | $45.10K 10-Q · filed 2021-08-12 | |||||
| 2020-03-31 | $15.60K 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |